Vivus
Vivus (OTC Pink: VVUSQ) is a small pharmaceutical company headquartered in Campbell, California that specializes in obesity, sleep, and sexual health. Vivus developed Avanafil, an erectile dysfunction drug that has completed Phase 3 clinical trials.[1] The drug has been approved for use by the Food and Drug Administration, and is sold under the trademark name Stendra.[2] Stendra is the first and only oral erectile dysfunction treatment approved to be taken approximately 15 minutes before sexual activity.[3]
Overview
[edit]The 2009 documentary film "Orgasm Inc." was made at Vivus to document the process of creating a treatment for female sexual arousal disorder (FSD).
Vivus also developed an obesity drug, Qnexa (now called Qsymia), a combination of phentermine and topiramate, two existing weight-loss drugs.[4] On July 17, 2012, the Food and Drug Administration approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. The drug was approved for use in adults with a body mass index (BMI) of 30 or greater (obese) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).[5][6]
In 2016, the company was ranked #23 on the Deloitte Fast 500 North America list.[7]
In 2020, the company filed for bankruptcy protection.[8]
References
[edit]- ↑ Phase 3 Data on VIVUS' Avanafil for Erectile Dysfunction to be Featured at the AUA 2010 Annual Meeting, ""
- ↑ "Most Popular in Your Life". USA Today.
- ↑ "VIVUS and Auxilium Announce Stendra Label Expansion". Zacks Investment Research.
- ↑ Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP), "[permanent dead link]"
- ↑ Hellmich, Nancy (17 July 2012). "New diet drug helps patients lose about 10% of weight". USA Today. Archived from the original on 18 July 2012. Retrieved 17 July 2012.
- ↑ "Medications Target Long-Term Weight Control". FDA.gov. Archived from the original on July 20, 2012. Retrieved 17 July 2012.
- ↑ "2016 Winners by rank" (PDF). Deloitte. Archived from the original (PDF) on 21 November 2016. Retrieved 14 October 2017.
- ↑ "Drugmaker Vivus Files for Bankruptcy in Deal With IEH". The Wall Street Journal. July 7, 2020.
External links
[edit]- Official website
- Business data for Vivus:
